Literature DB >> 23912226

The role of tumor necrosis factor-α in the pathogenesis of vitiligo.

Carlos R Camara-Lemarroy1, Julio C Salas-Alanis.   

Abstract

Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912226     DOI: 10.1007/s40257-013-0039-3

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  7 in total

Review 1.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.

Authors:  Nesrine Boukhedouni; Christina Martins; Anne-Sophie Darrigade; Claire Drullion; Jérôme Rambert; Christine Barrault; Julien Garnier; Clément Jacquemin; Denis Thiolat; Fabienne Lucchese; Franck Morel; Khaled Ezzedine; Alain Taieb; François-Xavier Bernard; Julien Seneschal; Katia Boniface
Journal:  JCI Insight       Date:  2020-06-04

3.  Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.

Authors:  Natalia Aranza Zapata-Salazar; David Emmanuel Kubelis-Lopez; Mauricio Andres Salinas-Santander; Celia Nohemi Sanchez-Dominguez; Ana Cecilia Xolalpa-Rosales; Marely Eugenia Gomez-Galindo; Jorge Ocampo-Candiani
Journal:  Arch Dermatol Res       Date:  2022-08-12       Impact factor: 3.033

4.  No Association between Vitiligo and Obesity: A Case-Control Study.

Authors:  Federica Dragoni; Rossana Conti; Simone Cazzaniga; Roberta Colucci; Lisa Pisaneschi; Luigi Naldi; Silvia Moretti
Journal:  Med Princ Pract       Date:  2017-09-12       Impact factor: 1.927

5.  Therapeutic effects of iNOS inhibition against vitiligo in an animal model.

Authors:  Hamid Mansourpour; Katayoun Ziari; Sahar Kalantar Motamedi; Amin Hassan Poor
Journal:  Eur J Transl Myol       Date:  2019-08-06

Review 6.  Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.

Authors:  Paolo Custurone; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Domenica Altavilla; Alessandra Bitto; Giovanni Pallio; Francesco Squadrito; Mario Vaccaro
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  Evaluation of the Efficacy of Topical Tetracycline in Enhancing the Effect of Narrow Band UVB against Vitiligo: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Amir Kalafi; Farideh Jowkar
Journal:  ISRN Dermatol       Date:  2014-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.